Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Genitourinary 7Breast 6Tumor-Agnostic 2Thoracic 2Lymphoid 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Hematologic Neoplasms 1

Interventions

Cyclophosphamide 34Cytarabine 33Exercise 25Blood Specimen Collection 24venetoclax 23fludarabine phosphate 22Busulfan 22fludarabine 18Methotrexate 18Methods 18Cyclosporine 18Peripheral Blood Stem Cell Transplantation 17Filgrastim 17Antilymphocyte Serum 17Standard of Care 16Whole-Body Irradiation 15Granulocyte Colony-Stimulating Factor 15Educational Status 15Early Intervention, Educational 15Palliative Care 14Melphalan 14Daunorubicin 14Mycophenolic Acid 13Azacitidine 13Practice Guidelines as Topic 12Etoposide 12Dexamethasone 12Radiotherapy 11Vincristine 9Therapeutics 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × High-Intensity Interval Training × Other hematologic neoplasm × Clear all
NCT03823651 2024-09-27

A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)

Duke University

Phase NA Completed
29 enrolled 14 charts
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡